Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$808 Buy
+185
New +$1.01K ﹤0.01% 7537
2023
Q2
Hold
0
-$3 7692
2023
Q1
Hold
0
7690
2022
Q4
Hold
0
7874
2022
Q3
Sell
-316
Closed -$70.5K 7833
2022
Q2
$64K Sell
316
-10
-3% -$2.5K ﹤0.01% 6500
2022
Q1
$123K Buy
326
+316
+3,160% +$120K ﹤0.01% 6188
2021
Q4
$4K Buy
+10
New +$5.76K ﹤0.01% 7694
2021
Q3
Hold
0
8003
2021
Q2
Hold
0
7787
2021
Q1
Hold
0
7542
2020
Q4
Hold
0
7095
2020
Q3
Hold
0
6808
2020
Q2
Hold
0
6697
2020
Q1
Hold
0
6676
2019
Q4
Hold
0
6739
2019
Q3
Hold
0
6726
2019
Q2
Hold
0
6718
2019
Q1
Hold
0
6528
2018
Q4
Hold
0
6700
2018
Q3
Hold
0
6777
2018
Q2
Hold
0
6726
2018
Q1
Hold
0
6552
2017
Q4
Hold
0
6500
2017
Q3
Hold
0
6461
2017
Q2
Hold
0
6461
2017
Q1
Hold
0
6386
2016
Q4
Hold
0
6307
2016
Q3
Hold
0
6439
2016
Q2
Hold
0
6368
2016
Q1
Hold
0
6481
2015
Q4
Hold
0
6511
2015
Q3
Hold
0
6419
2015
Q2
Hold
0
5745
2015
Q1
Hold
0
6006
2014
Q4
Hold
0
5767
2014
Q3
Hold
0
6080
2014
Q2
Hold
0
4934
2014
Q1
Hold
0
4720
2013
Q4
Hold
0
4607
2013
Q3
Hold
0
4550
2013
Q2
Hold
0
4497

Other funds holding CNSY

Morgan Stanley's CNSY Position: Q2 2026 in Review

Morgan Stanley opened a new position in Cerenome (CNSY) in Q2 2026: 185 shares worth $808. The stake represents ﹤0.01% of the portfolio and ranks #7537 among its holdings. This is a return to the name: Morgan Stanley previously reported a position in CNSY as recently as Q2 2022.

Morgan Stanley first reported a position in CNSY in Q4 2021 and has held it in 4 quarters since. The position peaked at $123K in Q1 2022. 21 funds tracked by Wall St. Rank hold CNSY as of Q2 2026.

  • Morgan Stanley held 185 shares of Cerenome worth $808 as of Q2 2026.
  • Cerenome was a new Morgan Stanley position in Q2 2026.
  • Cerenome made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7537 holding.
  • Morgan Stanley first reported a position in Cerenome in Q4 2021 and has held it in 4 quarters since.
  • Morgan Stanley's Cerenome position peaked at $123K in Q1 2022.
  • 21 funds tracked by Wall St. Rank held Cerenome as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.